U.S. markets closed
  • S&P Futures

    4,005.75
    -26.75 (-0.66%)
     
  • Dow Futures

    34,185.00
    -171.00 (-0.50%)
     
  • Nasdaq Futures

    11,687.00
    -95.75 (-0.81%)
     
  • Russell 2000 Futures

    1,856.30
    -13.90 (-0.74%)
     
  • Crude Oil

    74.04
    -2.24 (-2.94%)
     
  • Gold

    1,748.70
    -5.30 (-0.30%)
     
  • Silver

    21.17
    -0.26 (-1.21%)
     
  • EUR/USD

    1.0362
    -0.0043 (-0.41%)
     
  • 10-Yr Bond

    3.6910
    -0.0150 (-0.40%)
     
  • Vix

    20.50
    +0.08 (+0.39%)
     
  • GBP/USD

    1.2042
    -0.0048 (-0.40%)
     
  • USD/JPY

    138.4350
    -0.6650 (-0.48%)
     
  • BTC-USD

    16,134.47
    -373.01 (-2.26%)
     
  • CMC Crypto 200

    378.13
    -4.52 (-1.18%)
     
  • FTSE 100

    7,486.67
    +20.07 (+0.27%)
     
  • Nikkei 225

    28,079.68
    -203.35 (-0.72%)
     

Berkeley Lights (BLI) in Focus: Stock Moves 6.3% Higher

Berkeley Lights, Inc. BLI was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continue the recent uptrend for the company — as the stock is now up 12.4% in the past one-month time frame.

The company has seen no estimates revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Berkeley Lights currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Berkeley Lights, Inc. Price

Berkeley Lights, Inc. Price
Berkeley Lights, Inc. Price

Berkeley Lights, Inc. price | Berkeley Lights, Inc. Quote

A better-ranked stock in the Medical sector is Alimera Sciences, Inc. ALIM, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alimera Sciences, Inc. (ALIM) : Free Stock Analysis Report
 
Berkeley Lights, Inc. (BLI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research